This Startup Backed By OpenAI and Jobs Family Is the Latest A.I. Drug Discovery Unicorn |
Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery
Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug discovery company to benefit from a flurry of investments at the intersection of health care and A.I. In its latest funding round, the company raised $130 million to accelerate the development of new drugs. The Series B round, announced today (Dec. 15), was co-led by Oak HC/FT and General Catalyst. It brings Chai Discovery’s total funding to more than $225 million and more than doubles its valuation to $1.3 billion.
Sign Up For Our Daily Newsletter
Sign UpThank you for signing up!
By clicking submit, you agree to our terms of service and acknowledge we may use your information to send you emails, product samples, and promotions on this website and other........